Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.
Nagarajan RP
,
Chen F
,
Li W
,
Vig E
,
Harrington MA
,
Nakshatri H
,
Chen Y
.
???displayArticle.abstract???
Activation of transforming growth factor-beta (TGF-beta) and activin receptors leads to phosphorylation of Sma- and Mad-related protein 2 (Smad2) and Smad3, which function as transcription factors to regulate gene expression. Smad7 is a regulatory protein which is able to inhibit TGF-beta and activin signalling in a negative-feedback loop, mediated by a direct regulation by Smad3 and Smad4 via a Smad-binding element (SBE) in the Smad7 promoter. Interestingly, we found that the Smad7 promoter was also regulated by nuclear factor kappaB (NF-kappaB), a transcription factor which plays an important role in inflammation and the immune response. Expression of NF-kappaBp65 subunit was able to inhibit the Smad7 promoter activity, and this inhibition could be reversed by co-expression of IkappaB, an inhibitor of NF-kappaB. In addition, the inhibitory activity of p65 was observed in a minimal promoter that contained only the Smad7 SBE and a TATA box, without any consensus NF-kappaB binding site. This inhibitory effect appeared to be common to other TGF-beta- and activin-responsive promoters, since p65 also inhibited the forkhead-activin-signal-transducer-2-mediated activation of a Xenopus Mix.2 promoter, as well as the Smad3-mediated activation of 3TP-lux which contains PMA-responsive elements and a plasminogen-activator-inhibitor-1 promoter. Activation of endogenous NF-kappaB by tumour necrosis factor-alpha (TNF-alpha) was also able to inhibit the Smad7 promoter in human embryonic kidney 293 cells. In human hepatoma HepG2 cells, TNF-alpha was able to inhibit TGF-beta- and activin-mediated transcriptional activation. Furthermore, overexpression of the transcription co-activator p300 could abrogate the inhibitory effect of NF-kappaB on the Smad7 promoter. Taken together, these data have indicated a novel mode of crosstalk between the Smad and the NF-kappaB signalling cascades at the transcriptional level by competing for a limiting pool of transcription co-activators.
Arsura,
Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.
1997,
Pubmed
Arsura,
TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha.
1996,
Pubmed
Baeuerle,
NF-kappa B: ten years after.
1996,
Pubmed
Baldwin,
The NF-kappa B and I kappa B proteins: new discoveries and insights.
1996,
Pubmed
Bitzer,
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
2000,
Pubmed
Chen,
Smad4 and FAST-1 in the assembly of activin-responsive factor.
1997,
Pubmed
,
Xenbase
Chen,
Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins.
1996,
Pubmed
,
Xenbase
Chen,
A transcriptional partner for MAD proteins in TGF-beta signalling.
1996,
Pubmed
,
Xenbase
Dennler,
Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
1998,
Pubmed
Feng,
The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.
1998,
Pubmed
Gerritsen,
CREB-binding protein/p300 are transcriptional coactivators of p65.
1997,
Pubmed
Hedin,
Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element.
1997,
Pubmed
Heldin,
TGF-beta signalling from cell membrane to nucleus through SMAD proteins.
1997,
Pubmed
Hottiger,
Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.
1998,
Pubmed
Huang,
Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo.
1995,
Pubmed
,
Xenbase
Ishisaki,
Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells.
1998,
Pubmed
Janknecht,
TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300.
1998,
Pubmed
Kon,
Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression.
1999,
Pubmed
Labbé,
Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2.
1998,
Pubmed
,
Xenbase
Lagna,
Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.
1996,
Pubmed
,
Xenbase
Li,
Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity.
1998,
Pubmed
Liu,
FAST-2 is a mammalian winged-helix protein which mediates transforming growth factor beta signals.
1999,
Pubmed
,
Xenbase
Massagué,
TGF-beta signal transduction.
1998,
Pubmed
Nabel,
An inducible transcription factor activates expression of human immunodeficiency virus in T cells.
,
Pubmed
Nagarajan,
Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
1999,
Pubmed
,
Xenbase
Nagarajan,
Regulation of Smad7 promoter by direct association with Smad3 and Smad4.
1999,
Pubmed
Nakao,
Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling.
1997,
Pubmed
,
Xenbase
Nakshatri,
Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
1997,
Pubmed
Parks,
Organization of the transcriptional control region of the E1b gene of adenovirus type 5.
1988,
Pubmed
Perkins,
Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator.
1997,
Pubmed
Pouponnot,
Physical and functional interaction of SMADs and p300/CBP.
1998,
Pubmed
Stein,
Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.
1993,
Pubmed
Vanden Berghe,
The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter.
1999,
Pubmed
Vig,
Modulation of tumor necrosis factor and interleukin-1-dependent NF-kappaB activity by mPLK/IRAK.
1999,
Pubmed
Wallach,
Tumor necrosis factor receptor and Fas signaling mechanisms.
1999,
Pubmed
Webster,
Transcriptional cross talk between NF-kappaB and p53.
1999,
Pubmed
Wrana,
TGF beta signals through a heteromeric protein kinase receptor complex.
1992,
Pubmed
Zabel,
DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition.
1991,
Pubmed
Zhang,
Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
1998,
Pubmed
